CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

zinc

Small moleculeexperimental

There is no available information related any biological and pharmaceutical application of ammonium tetrachlorozincate. — NCATS

Clinical trial activity

220 trials · 285 clinical orgs · 0 marketing orgs

Phase 1
16
Phase 2
71
Phase 3
53
Phase 4
26

Earliest trial started Sep 1, 1990 (NCT00000145)

Timeline

1990s

  1. Jan 1, 1990

    Earliest Phase 3 Sponsor(trial)

2000s

  1. Jan 1, 2003

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2003

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • ZincSupplementation

    Zinc supplementation

Chemistry & pharmacology

Loading structure…

SMILES

[Zn++]
Mol. weight
65.409 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 30zn
  • 30zn
  • cinc
  • cinc
  • npc-02
  • zicam
  • zinc
  • zinc
  • zinc
  • zinc
  • zincum
  • zincum
  • zinic
  • zink
  • zink
  • zn
  • zn
  • zn2+
  • zn2+
  • zn(ii)
  • zn(ii)

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07270042N/ADec 1, 2025Tishreen University
NCT06260891Phase 2Nov 30, 2025Baylor University, Duke University, Georgetown University, Newark Beth Israel Medical Center, The American Society of Hematology, Thomas Jefferson University, University of California, San Francisco, University of Cincinnati, University of Pennsylvania
NCT07153549N/ASep 20, 2025Hai Phong Medical University
NCT06807996N/AJul 1, 2025Huazhong University of Science and Technology
NCT07050693N/AApr 17, 2025University of Bari
NCT06856590N/AFeb 20, 2025Gazi University
NCT06817512N/AFeb 15, 2025Harbin Medical University
NCT06567717Phase 2Jan 31, 2025Cedars-Sinai Medical Center
NCT06612554N/AJan 2, 2025Institut Hospital del Mar d'Investigacions Mèdiques
NCT06673082N/ADec 1, 2024Cairo University
NCT06664008Phase 4Nov 1, 2024Ain Shams University, British University In Egypt
NCT06598072Phase 3Sep 17, 2024Colgate Palmolive, Universidad Autonoma de San Luis Potosi
NCT06607263Phase 3Sep 16, 2024Colgate Palmolive, Federal University of Rio Grande do Sul
NCT06674564N/ASep 9, 2024Ain Shams University
NCT06412653Phase 2Aug 2, 2024University of Cologne, University of Geneva
NCT06430060Phase 3Jun 30, 2024Colgate Palmolive
NCT06982703N/AJun 15, 2024University of Padova
NCT06102044Phase 3Mar 1, 2024Harvard University, Muhimbili University
NCT06348056N/AJan 22, 2024University of California, Berkeley
NCT06860620N/AJan 1, 2024Nishter Hospital Multan, Pakistan, RESnTEC, Institute of Research
Showing 20 of 220 trials
Page 1 / 11

Organizations

Research & Development (285)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
International Center for Diarrheal Disease ResearchAcademic/Hospital11851993
University of California, DavisAcademic/Hospital9732007
Colgate PalmoliveFor profit8532014
National Institutes of Health (NIH)Government7232003
University of California, San FranciscoAcademic/Hospital7632006
Harvard UniversityAcademic/Hospital6442007
Society for Applied Studies, New DelhiAcademic/Hospital6531998
Ain Shams UniversityAcademic/Hospital5532017
Cairo UniversityAcademic/Hospital5532013
Johns Hopkins UniversityAcademic/Hospital5452002
University of Sao PauloAcademic/Hospital5212008
World Health OrganizationGovernment5021998
All India Institute of Medical SciencesAcademic/Hospital4121998
Emory UniversityAcademic/Hospital4422009
Helen Keller InternationalAcademic/Hospital4022009
Swiss Federal Institute of TechnologyAcademic/Hospital4322010
Thrasher Research FundAcademic/Hospital4032000
University of IndonesiaAcademic/Hospital4431998
Washington University in St. LouisAcademic/Hospital4412011
Albert Einstein Israelite HospitalAcademic/Hospital3322020
285 organizations
Page 1 / 15